Amla and cholesterol
What 3 graded rows on amla agree on for cholesterol, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Amla page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Amla page, with its PubMed record.
Your question
Amla and cholesterol
3 rows · 860 peopleThey agree: all 3 rows found an improvement.
- CGrade C× 3
- Rows
- 3
- Trials
- 14
- People
- 860
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade C, is a meta-analysis of 535 people (2023) and found an improvement.
The rows run from 98 to 535 people, published from 2019 to 2023: 2 pooled reviews and 1 single study.
The rows
3 improved- CGrade CLDL cholesterol, triglycerides and hsCRP · Improved
Meta-analysis, 9 studies · n 535 · 2023 · Adults in 9 RCTs (healthy, dyslipidemia, diabetes and other groups)
500–1,500 mg/day · 14–84 days
LDL fell 15.1 mg/dL, triglycerides 22.4 mg/dL and hsCRP 1.7 mg/L vs placebo. Heterogeneity was high and prediction intervals crossed zero for LDL and triglycerides.
- CGrade CCholesterol in dyslipidemia (aqueous fruit extract) · Improved
Meta-analysis, 4 studies · n 227 · 2023 · Adults with dyslipidemia in 4 RCTs
Varied across trials (not stated in the abstract) · 12 weeks
Total cholesterol fell 21.2 mg/dL and LDL 25.1 mg/dL and HDL rose 4.7 mg/dL versus placebo; triglycerides did not differ. Heterogeneity was high and certainty low; side effects were mild (mostly dyspepsia).
- CGrade CLipids in dyslipidemia · Improved
RCT · n 98 · 2019 · Adults with dyslipidemia (India, multicenter)
500 mg twice daily (1,000 mg/day) · 12 weeks
Total cholesterol, triglycerides, LDL and VLDL were significantly lower than placebo; the atherogenic index fell 39%. CoQ10 did not change.